85 related articles for article (PubMed ID: 16039316)
1. Being realistic about benefits of supervised injecting facilities.
Hall W; Kimber J
Lancet; 2005 Jul 23-29; 366(9482):271-2. PubMed ID: 16039316
[No Abstract] [Full Text] [Related]
2. Safer injection facility use and syringe sharing in injection drug users.
Kerr T; Tyndall M; Li K; Montaner J; Wood E
Lancet; 2005 Jul 23-29; 366(9482):316-8. PubMed ID: 16039335
[TBL] [Abstract][Full Text] [Related]
3. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.
Milloy MJ; Wood E
Addiction; 2009 Apr; 104(4):620-1. PubMed ID: 19335659
[No Abstract] [Full Text] [Related]
4. Needle exchange as a safe haven in an unsafe world.
MacNeil J; Pauly B
Drug Alcohol Rev; 2011 Jan; 30(1):26-32. PubMed ID: 21219494
[TBL] [Abstract][Full Text] [Related]
5. Health promotion at the Medically Supervised Injecting Centre.
White M
Aust Nurs J; 2012 Sep; 20(3):43. PubMed ID: 23066588
[No Abstract] [Full Text] [Related]
6. Provision of bloodborne virus screening in substance misuse.
Harniman B
Nurs Times; 2006 Aug 1-7; 102(31):28-30. PubMed ID: 16913519
[TBL] [Abstract][Full Text] [Related]
7. 'You sort of switch off': exploring mindlessness in injecting drug users' accounts of blood.
Treloar C
J Health Psychol; 2005 Jan; 10(1):137-45. PubMed ID: 15576505
[TBL] [Abstract][Full Text] [Related]
8. [Controlled drug consumption rooms].
Allilaire JF; Costentin J; Goullé JP; Hamon M; Laqueille X; Lejoyeux M; Mouren MC; Olié JP; Nordmann R; Tillement JP
Bull Acad Natl Med; 2013 Feb; 197(2):503-5. PubMed ID: 24919375
[No Abstract] [Full Text] [Related]
9. Ireland is to install supervised injecting rooms.
Houston M
BMJ; 2016 Jan; 532():i406. PubMed ID: 26801053
[No Abstract] [Full Text] [Related]
10. Supervised consumption rooms: the French Paradox.
Jauffret-Roustide M; Pedrono G; Beltzer N
Int J Drug Policy; 2013 Nov; 24(6):628-30. PubMed ID: 23777651
[No Abstract] [Full Text] [Related]
11. Estimation of the number of injecting drug users attending an outreach syringe-exchange program and infection with human immunodeficiency virus (HIV) and hepatitis C virus: the AjUDE-Brasil project.
Caiaffa WT; Mingoti SA; Proietti FA; Carneiro-Proietti AB; Silva RC; Lopes AC; Doneda D
J Urban Health; 2003 Mar; 80(1):106-14. PubMed ID: 12612100
[TBL] [Abstract][Full Text] [Related]
12. Supervised injecting facilities: how much evidence is enough?
Maher L; Salmon A
Drug Alcohol Rev; 2007 Jul; 26(4):351-3. PubMed ID: 17564869
[No Abstract] [Full Text] [Related]
13. Attendance at supervised injecting facilities and use of detoxification services.
Wood E; Tyndall MW; Zhang R; Stoltz JA; Lai C; Montaner JS; Kerr T
N Engl J Med; 2006 Jun; 354(23):2512-4. PubMed ID: 16760459
[No Abstract] [Full Text] [Related]
14. Mobile safe injecting facilities in Barcelona and Berlin.
Dietze P; Winter R; Pedrana A; Leicht A; Majó I Roca X; Brugal MT
Int J Drug Policy; 2012 Jul; 23(4):257-60. PubMed ID: 22464795
[No Abstract] [Full Text] [Related]
15. Changes in injecting practices associated with the use of a medically supervised safer injection facility.
Stoltz JA; Wood E; Small W; Li K; Tyndall M; Montaner J; Kerr T
J Public Health (Oxf); 2007 Mar; 29(1):35-9. PubMed ID: 17229788
[TBL] [Abstract][Full Text] [Related]
16. Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.
Day CA; Topp L; Iversen J; Maher L;
Drug Alcohol Rev; 2008 Sep; 27(5):559-61. PubMed ID: 18608447
[No Abstract] [Full Text] [Related]
17. Do supervised injecting facilities attract higher-risk injection drug users?
Wood E; Tyndall MW; Li K; Lloyd-Smith E; Small W; Montaner JS; Kerr T
Am J Prev Med; 2005 Aug; 29(2):126-30. PubMed ID: 16005809
[TBL] [Abstract][Full Text] [Related]
18. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.
Miller CL; Tyndall M; Spittal P; Li K; Palepu A; Schechter MT
J Urban Health; 2002 Jun; 79(2):257-65. PubMed ID: 12023501
[TBL] [Abstract][Full Text] [Related]
19. HIV prevalence and risk behaviour in needle exchange attenders: a national study. The Collaboration of Australian Needle Exchanges.
MacDonald M; Wodak AD; Ali R; Crofts N; Cunningham PH; Dolan KA; Kelaher M; Loxley WM; van Beek I; Kaldor JM
Med J Aust; 1997 Mar; 166(5):237-40. PubMed ID: 9076266
[TBL] [Abstract][Full Text] [Related]
20. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
